NervGen Pharma Corp. Common stock
NGEN | NASDAQ
$1.44
+$0.07 (+5.11%)
Nov 2, 2026, 10:39 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 14.32K | 14.18K | -29.95K | 13.97K | 14.02K | 13.87K | 15.8K | 14.63K | 15.02K | 38.37K | 38.63K | 36.51K | 34.98K | 34.76K | 34.45K | 34.42K | 34.21K | 11.37K | 8.89K | 8.63K | 10.56K | 9.98K |
Gross Profit | -14.32K | -14.18K | 29.95K | -13.97K | -14.02K | -13.87K | -15.8K | -14.63K | -15.02K | -38.37K | -38.63K | -36.51K | -34.98K | -34.76K | -34.45K | -34.42K | -34.21K | -11.37K | -8.89K | -8.63K | -10.56K | -9.98K |
Operating Income | -12.52M | -7.66M | -11.7M | -6.18M | -6.5M | -6M | -6.8M | -7.21M | -6M | -4.98M | -4.88M | -3.41M | -4.77M | -4.72M | -6.72M | -4.88M | -6.31M | -5M | -3.29M | -2.91M | -2.76M | -2.23M |
Interest Income | 185.23K | 105.8K | 139.37K | 77.18K | 87.33K | 107.14K | 170.99K | 243.28K | 294.68K | 103.13K | 122.56K | 136.12K | 139.51K | 151.39K | 85.26K | 63.9K | 33.53K | 17.31K | 10.19K | 5.21K | 5.33K | 4.68K |
Pretax Income | -29.99M | -1.7M | -31.7M | -4.16M | -9.15M | -3.93M | -8.6M | -5.29M | -7.82M | -2.35M | -8.61M | -4.29M | -4.76M | -4.71M | -5.89M | -3.46M | -6.32M | -4.96M | -3.29M | -2.86M | -2.73M | -2.25M |
Net Income | -29.99M | -1.7M | -31.7M | -4.16M | -9.15M | -3.93M | -8.6M | -5.29M | -7.82M | -2.35M | -8.61M | -4.29M | -4.76M | -4.71M | -5.89M | -3.46M | -6.32M | -4.96M | -3.29M | -2.86M | -2.73M | -2.25M |
Selling & General & Admin | 4.42M | 2.71M | 5.18M | 1.73M | 3.78M | 2.86M | 2.21M | 2.8M | 2.2M | 1.98M | 2.18M | 2.55M | 3.22M | 1.67M | 1.66M | 1.7M | 1.54M | 1.4M | 1.28M | 1.31M | 1.19M | 1.48M |
Research & Development | 8.09M | 4.93M | 6.56M | 4.44M | 2.71M | 3.13M | 4.57M | 4.4M | 3.78M | 2.96M | 2.65M | 823.36K | 1.51M | 3.01M | 5.03M | 3.15M | 4.73M | 3.59M | 2M | 1.59M | 1.56M | 736.71K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.51M | 7.64M | 11.73M | 6.17M | 6.49M | 5.99M | 6.79M | 7.2M | 5.98M | 4.94M | 4.84M | 3.37M | 4.73M | 4.68M | 6.69M | 4.84M | 6.28M | 4.99M | 3.28M | 2.9M | 2.75M | 2.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 509.74K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.52M | 7.66M | 11.7M | 6.18M | 6.5M | 6M | 6.8M | 7.21M | 6M | 4.98M | 4.88M | 3.41M | 4.77M | 4.72M | 6.72M | 4.88M | 6.31M | 5M | 3.29M | 2.91M | 2.76M | 2.23M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 92.44M | 79.9M | 72.33M | 73.16M | 71.96M | 70.67M | 70.33M | 70.07M | 69.95M | 60.21M | 59.61M | 59.42M | 59.22M | 58.96M | 58.78M | 58.16M | 47.3M | 46.23M | 46.08M | 40.13M | 37.65M | 35.46M |
Shares Outstanding (Diluted) | 92.44M | 79.9M | 72.33M | 73.16M | 71.96M | 70.67M | 70.33M | 70.07M | 69.95M | 60.21M | 59.61M | 59.42M | 59.22M | 58.96M | 58.78M | 58.16M | 47.3M | 46.23M | 46.08M | 40.13M | 37.65M | 35.46M |
EPS (Basic) | -0.33 | -0.02 | -0.44 | -0.06 | -0.13 | -0.06 | -0.12 | -0.08 | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 | -0.07 | -0.07 | -0.07 | -0.06 |
EPS (Diluted) | -0.33 | -0.02 | -0.44 | -0.06 | -0.13 | -0.06 | -0.12 | -0.08 | -0.11 | -0.04 | -0.15 | -0.07 | -0.08 | -0.08 | -0.10 | -0.06 | -0.13 | -0.11 | -0.07 | -0.07 | -0.07 | -0.06 |
EBITDA | -12.51M | -1.69M | 6.73M | -4.15M | -9.13M | -3.91M | -8.59M | -5.27M | -7.81M | -2.31M | -8.57M | -4.25M | -4.72M | -4.67M | -5.85M | -2.92M | -6.28M | -4.95M | -3.28M | -2.85M | -2.72M | -2.24M |
EBIT | -12.52M | -1.7M | 6.71M | -4.16M | -9.15M | -3.93M | -8.6M | -5.29M | -7.82M | -2.35M | -8.61M | -4.29M | -4.76M | -4.71M | -5.89M | -2.95M | -6.32M | -4.96M | -3.29M | -2.86M | -2.73M | -2.25M |
Depreciation & Amortization | 14.32K | 14.18K | 25.84K | 13.97K | 14.02K | 13.87K | 15.8K | 14.63K | 15.02K | 38.37K | 38.63K | 36.51K | 34.98K | 34.76K | 34.45K | 34.42K | 34.21K | 11.37K | 8.89K | 8.63K | 10.56K | 9.98K |
Add to Watchlist
Select watchlists to add or remove NGEN